Indalo Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Indalo Therapeutics's estimated annual revenue is currently $620k per year.
- Indalo Therapeutics's estimated revenue per employee is $155,000
Employee Data
- Indalo Therapeutics has 4 Employees.
- Indalo Therapeutics grew their employee count by 0% last year.
Indalo Therapeutics's People
| Name | Title | Email/Phone |
|---|
Indalo Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Indalo Therapeutics?
Indalo Therapeutics is a biopharmaceutical company discovering and developing integrin antagonists for patients suffering from serious fibrotic diseases such as nonalcoholic steatohepatitis (NASH) and idiopathic pulmonary fibrosis (IPF). Our lead drug candidate, IDL-2965, began human clinical trials in early 2019. IDL-2965 provides potent antifibrotic efficacy at low once-daily oral doses across multiple animal models of disease in vital organ systems, including liver, lung, and kidney. Our innovative approach builds upon a solid foundation that includes: - A history of scientific and business achievement: Our R&D leadership team was responsible for the development and approval of Esbriet® for IPF at InterMune. - A legacy of deep target knowledge: Our founding scientists have decades of experience in the design, characterization, and development of integrin antagonists. - Marquee investors: Atlas Venture and F-Prime have an unparalleled track record of fostering innovation.
keywords:N/A
N/A
Total Funding
4
Number of Employees
$620k
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Cambridge
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.1M | 4 | -56% | $20.4M |
#2 | $0.3M | 4 | N/A | N/A |
#3 | $0.1M | 4 | 0% | $13.2M |
#4 | $0.3M | 4 | 33% | N/A |
#5 | $1M | 4 | 0% | N/A |